+44 1300 500008Journal of Antivirals & Antiretrovirals : Citations & Metrics Report
Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.
Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
59 | 57 | 32 | 59 | 77 | 13 | 11 | 20 | 37 | 22 | 37 | 55 | 22 | 12 |
Research, Review articles and Editorials |
1 | 0 | 5 | 42 | 32 | 12 | 10 | 14 | 27 | 21 | 33 | 44 | 21 | 10 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
48 | 57 | 27 | 17 | 45 | 1 | 1 | 6 | 10 | 1 | 4 | 11 | 1 | 2 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 35 | 51 | 125 | 100 | 191 | 0 | 125 | 177 |
Citations received as per Google Scholar, other indexing platforms and portals |
98 | 160 | 172 | 269 | 223 | 172 | 219 | 195 | 170 | 116 | 60 | 36 | 26 | 58 |
| Journal total citations count | 2004 |
| Journal impact factor | 5.32 |
| Journal 5 years impact factor | 5.62 |
| Journal cite score | 5.3 |
| Journal h-index | 22 |
| Journal h-index since 2019 | 17 |
Important citations (1101)
frenzel a, schirrmann t, hust m. phage display-derived human antibodies in clinical development and therapy. mabs. 2016;8: 1177-1194. |
|
lim bn, tye gj, choong ys, ong eb, ismail a, et al. (2014) principles and application of antibody libraries for infectious diseases. biotechnology letters. 36: 2381-2392. |
|
naga anusha p. risk factors in hepatocellular carcinoma. j cancer sci ther. 2010: s17. |
|
soumya d, hima bindu a. opportunistic diseases as a consequence of hiv/aids. j aids clin res. 2011; 2: 5. |
|
soumya d, hima bindu a. opportunistic diseases as a consequence of hiv/aids. j aids clin res. 2011;2: 5. |
|
naga anusha p. antiretroviral strategies for treatment of hiv. j antivir antiretrovir. 2011;1: 2. |
|
jeevani t. stem cell transplantation-types, risks and benefits. j stem cell res ther. 2011; 1: 3. |
|
arun kumar r, sathish kumar d, nishanth t. a review on stem cell research & their role in various diseases. j stem cell res ther. 2011;1: 1-5. |
|
siddiqui a, jeevani t, naga anusha p, hima bindu a. stem cell therapy for liver diseases. j stem cell res ther. 2011; 1: 2. |
|
silva da impact of human immunodeficiency virus infection on myocardial deformation: a research project (doctoral dissertation). |
|
yaser elnahar md, joseph daoko md, anthony al-dehneh md, nishant gupta md, vincent a. risk factors for the development of atrial fibrillation in hiv infected patients. j atr fibrillation. 2011;4(6): 404 |
|
elnahar y, daoko j, al-dehneh a, gupta n, debari va. risk factors for the development of atrial fibrillation in hiv infected patients. jafib: j atr fibrillation. 2012;1: 2. |
|
Soumya d, hima bindu a. opportunistic diseases as a consequence of hiv/aids. j aids clin res. 2011;2: 5. |
|
naga anusha p. antiretroviral strategies for treatment of hiv. j antivir antiretrovir. 2011; 1: 2. |
|
hima bindu a, naga anusha p. adverse effects of highly active anti-retroviral therapy (haart). j antivir antiretrovir. 2011;3: 060-064. |
|
praveenya p, singh bk, sathish kumar d, kalyan p. antibiotic resistance creating new epoch. j bacteriol parasitol. 2012;3: 2. |
|
opportunistic diseases as a consequence of hiv/aids |
|
antiretroviral strategies for treatment of hiv |
|
chemotherapy of influenza: current and novel approach |
|
r lingappa v, r hurt c, garvey e. capsid assembly as a point of intervention for novel anti-viral therapeutics. current pharmaceutical biotechnology. 2013;14: 513-523. |
|